← SynDRA
Dofequidar fumarate
SynDRA canonical compound SYN1960542 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ABCB1 | ABCC1 |
|---|
| Mechanism of action | mrp inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MRP INHIBITOR
- ABCB4 MODULATOR
Cross-references
Synonyms
- MS-209
- 1-(Diphenylacetyl)-4-[(2RS)-2-hydroxy-3-(5-quinolyloxy)propyl]piperazine sesquifumarate
- 1-[4-(2,2-Diphenylacetyl)piperazin-1-yl]-3-(quinoliln-5-yloxy)-2-propanol sesquifumarate
- 5-[3-[4-(2,2-Diphenylacetyl)piperazin-1-yl]-2-hydroxypropoxy]quinoline sesquifumarate
Look up Dofequidar fumarate in the interactive SynDRA portal →